1995
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus
Chu C, Ma T, Shanmuganathan K, Wang C, Xiang Y, Pai S, Yao G, Sommadossi J, Cheng Y. Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrobial Agents And Chemotherapy 1995, 39: 979-981. PMID: 7786007, PMCID: PMC162665, DOI: 10.1128/aac.39.4.979.Peer-Reviewed Original Research
1993
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification
Yao G, Grill S, Egan W, Cheng Y. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification. Antimicrobial Agents And Chemotherapy 1993, 37: 1420-1425. PMID: 8395789, PMCID: PMC187987, DOI: 10.1128/aac.37.7.1420.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusEpstein-Barr virus genesEBV DNA synthesisMechanism of actionEBV DNAEBV replicationS-oligoDrug exposureEBV agentsInhibitory doseViral DNA polymeraseVirus productionDosePotent inhibitionPhosphorothioate oligodeoxynucleotidePotent inhibitorInhibitionCell growthCell culturesDNA synthesisVirus genes